Agilent Technologies (NYSE:A) Releases Q1 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its first quarter 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 1.350-1.380 for the period, compared to the consensus estimate of 1.420. The company issued revenue guidance of $1.8 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion. Agilent Technologies also updated its FY 2026 guidance to 5.860-6.000 EPS.

Agilent Technologies Price Performance

Agilent Technologies stock traded up $1.99 during trading hours on Monday, hitting $153.24. 3,920,618 shares of the company traded hands, compared to its average volume of 1,902,329. Agilent Technologies has a 1-year low of $96.43 and a 1-year high of $153.84. The firm has a market cap of $43.44 billion, a P/E ratio of 35.97, a P/E/G ratio of 4.67 and a beta of 1.29. The firm’s 50-day simple moving average is $139.65 and its two-hundred day simple moving average is $125.37. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.59. The company had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts forecast that Agilent Technologies will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, January 6th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is 23.94%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on A shares. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. JPMorgan Chase & Co. upped their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Finally, Evercore ISI raised their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research report on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 911 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the transaction, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. This trade represents a 2.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.26% of the company’s stock.

Institutional Investors Weigh In On Agilent Technologies

Several hedge funds have recently made changes to their positions in the company. CIBC Bancorp USA Inc. purchased a new position in Agilent Technologies during the 3rd quarter worth approximately $5,030,000. Captrust Financial Advisors boosted its stake in shares of Agilent Technologies by 2.4% during the 3rd quarter. Captrust Financial Advisors now owns 43,179 shares of the medical research company’s stock valued at $5,542,000 after buying an additional 1,021 shares during the period. Coldstream Capital Management Inc. grew its stake in Agilent Technologies by 16.8% in the third quarter. Coldstream Capital Management Inc. now owns 5,640 shares of the medical research company’s stock valued at $724,000 after purchasing an additional 813 shares in the last quarter. Morningstar Investment Management LLC acquired a new position in Agilent Technologies in the third quarter worth approximately $2,118,000. Finally, CANADA LIFE ASSURANCE Co raised its holdings in shares of Agilent Technologies by 1.6% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 283,844 shares of the medical research company’s stock valued at $35,132,000 after purchasing an additional 4,545 shares in the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.